Accendra Health (ACH) Cash from Financing Activities (2009 - 2026)

Accendra Health (ACH) has reported Cash from Financing Activities for 18 consecutive years, with -$272.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Financing Activities fell 958.0% year-over-year to -$272.0 million in Q2 2026; TTM through Jun 2026 was -$157.3 million, a 33.07% decrease from a year earlier, with the FY2025 full-year figure at $188.1 million, up 170.28% from the prior year.
• Cash from Financing Activities was -$272.0 million for Q2 2026 at Accendra Health, down from $51.1 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $1.7 billion in Q1 2022 and troughed at -$272.0 million in Q2 2026.
• A 5-year average of $43.3 million and a median of -$53.4 million in 2023 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities soared 2170.05% in 2022 and slumped 958.0% in 2026, its largest moves.
• Over 5 years, Cash from Financing Activities stood at -$63.5 million in 2022, then rose by 19.32% to -$51.2 million in 2023, then rose by 15.85% to -$43.1 million in 2024, then sank by 172.64% to -$117.5 million in 2025, then tumbled by 131.48% to -$272.0 million in 2026.
• The last three Cash from Financing Activities figures came in at -$272.0 million (Q2 2026), $51.1 million (Q1 2026), and -$117.5 million (Q4 2025), per Business Quant data.